NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ: NMTC · Real-Time Price · USD
4.600
+0.090 (2.00%)
At close: May 14, 2026, 4:00 PM EDT
4.700
+0.100 (2.17%)
After-hours: May 14, 2026, 7:54 PM EDT
NeuroOne Medical Technologies Employees
NeuroOne Medical Technologies had 18 employees as of September 30, 2025. The number of employees increased by 1 or 5.88% compared to the previous year.
Employees
18
Change (1Y)
1
Growth (1Y)
5.88%
Revenue / Employee
$706,711
Profits / Employee
-$369,092
Market Cap
38.86M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 18 | 1 | 5.88% |
| Sep 30, 2024 | 17 | 1 | 6.25% |
| Sep 30, 2023 | 16 | 1 | 6.67% |
| Sep 30, 2022 | 15 | 4 | 36.36% |
| Sep 30, 2021 | 11 | 7 | 175.00% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Accuray | 990 |
| Nortech Systems | 713 |
| Pulmonx | 296 |
| TELA Bio | 209 |
| Myomo | 195 |
| Baird Medical Investment Holdings | 146 |
| Cytosorbents | 129 |
| electroCore | 83 |
NMTC News
- 1 day ago - NeuroOne Medical target adjusted to $8 from $1.60 at Ladenburg - TheFly
- 2 days ago - NeuroOne Medical Technologies Earnings Call Transcript: Q2 2026 - Transcripts
- 4 weeks ago - NeuroOne Medical Technologies trading halted, news pending - TheFly
- 2 months ago - NeuroOne Medical Technologies Transcript: Oppenheimer 36th Annual Healthcare MedTech & Services Conference - Transcripts
- 2 months ago - NeuroOne Medical Technologies Transcript: Investor update - Transcripts
- 2 months ago - NeuroOne Medical initiated with a Buy at JonesResearch - TheFly
- 3 months ago - NeuroOne Medical Technologies Earnings Call Transcript: Q1 2026 - Transcripts
- 5 months ago - NeuroOne Medical Technologies Earnings Call Transcript: Q4 2025 - Transcripts